Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inmed Pharmaceuticals Inc (NQ: INM ) 0.2516 -0.0098 (-3.75%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inmed Pharmaceuticals Inc < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > InMed Pharmaceuticals' Study Marks First Phase 2 Trial to Evaluate Cannabinol for Disease Treatment December 10, 2021 InMed Pharmaceuticals (NASDAQ: INM) recently released its Q1 2022 financial results along with a business update showing positive momentum across all of its programs. Following... Via Benzinga InMed Pharmaceuticals’ (NASDAQ: INM) Study Marks First Phase 2 Trial to Evaluate Cannabinol for Disease Treatment December 10, 2021 Via Investor Brand Network BioMedNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Study Marks First Phase 2 Trial to Evaluate Cannabinol as Therapeutic Option for Disease Treatment December 09, 2021 Via Investor Brand Network InMed Pharmaceuticals Targeting Potential Therapeutics Addressing Unmet Needs December 01, 2021 InMed Pharmaceuticals (NASDAQ: INM) recently filed a Patent Cooperation Treaty (“PCT”) application, which specifies a rare cannabinoid (new to InMed’s portfolio... Via Benzinga Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Strategy Toward Potential Therapeutics for Diseases with High Unmet Needs November 30, 2021 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Strategy Toward Potential Therapeutics for Diseases with High Unmet Needs November 30, 2021 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property InMed Pharmaceuticals Releases Q1 2022 Financial Results, Business Update November 29, 2021 InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021 November 29, 2021 Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE: Via Benzinga InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs November 29, 2021 Via Investor Brand Network InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs November 29, 2021 Via CannabisNewsWire InMed Pharmaceuticals Announces Participation in Upcoming Cannabis Conference November 23, 2021 InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing, and commercialization of rare cannabinoids, will be participating in the 4th annual Cowen Cannabis... Via Benzinga Topics Cannabis Exposures Cannabis InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Cannabis Conference November 23, 2021 Via Investor Brand Network Topics Cannabis Exposures Cannabis Welcome to the Party $INM! Competition or Compliment to $SNDL? — Cannabis Daily November 18, 2021 November 18, 2021 The Best Daily Overview Of The Cannabis Space South Dakota lawmakers recommend bill to legalize marijuana. New York ban... Via Benzinga Topics Cannabis Exposures Cannabis 44 Stocks Moving In Thursday's Mid-Day Session November 18, 2021 Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the... Via Benzinga Exposures Product Safety 54 Biggest Movers From Yesterday November 19, 2021 Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company... Via Benzinga Exposures Product Safety Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 18, 2021 Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Thursday! Via InvestorPlace 24 Stocks Moving in Thursday's Pre-Market Session November 18, 2021 Gainers Sono Group N.V. (NASDAQ: SEV) rose 33% to $50.80 in pre-market trading. Sono Group shares climbed 155% on Wednesday after the company priced its IPO at $15 per share.... Via Benzinga Topics Initial Public Offering Exposures Securities Market InMed Pharmaceuticals Working to Address Rare Cannabinoid Opportunities November 17, 2021 InMed Pharmaceuticals (NASDAQ: Via Benzinga InMed Pharmaceuticals (INM): Progress Across the Business November 17, 2021 LONDON, UK / ACCESSWIRE / November 17, 2021 / With the recent closing of the BayMedica acquisition, InMed now has a substantially different profile than just a few months ago. The company is now in its... From Edison Investment Research Limited Via AccessWire BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Working on Answer to Mass Production of Rare, Otherwise Depleted Cannabinoid Opportunities November 16, 2021 Via Investor Brand Network Topics Cannabis Exposures Cannabis InMed Pharmaceuticals Files Patent Application for Treatment of Neurodegenerative Diseases with Rare Cannabinoid November 11, 2021 InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabi... Via Benzinga Topics Intellectual Property Exposures Intellectual Property InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid November 10, 2021 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid November 10, 2021 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Results, Business Updates for Q1 2022 November 10, 2021 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InMed Pharmaceuticals Inc. Files PCT Application for Treating Neurodegenerative Disease Using Rare Cannabinoid November 03, 2021 InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development, and commercialization of rare cannabinoids, today announced its filing of an international patent... Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Files PCT Application for Treating Neurodegenerative Disease Using Rare Cannabinoid November 03, 2021 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities November 02, 2021 Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly-listed Ginkgo Bioworks Holdings Inc., in what is the largest-... Via Benzinga Topics Initial Public Offering Exposures Securities Market Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production November 01, 2021 Via Investor Brand Network Topics Initial Public Offering Exposures Securities Market Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production November 01, 2021 Via CannabisNewsWire Topics Initial Public Offering Exposures Securities Market 55 Biggest Movers From Friday October 25, 2021 Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World... Via Benzinga < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.